Dr. C. W. Tornøe (Novo Nordisk, Måløv, Denmark)vergrößern
Protein Synthesis and Crystallization of Bowman–Birk Protease Inhibitors
Christian Tornøe reports the protein synthesis and crystallization of Bowman–Birk protease inhibitors.
Divergent Protein Synthesis of Bowman–Birk Protease Inhibitors, their Hydrodynamic Behavior and Co-crystallization with α-Chymotrypsin: C. W. Tornøe, E Johansson, P.-O. Wahlund
Synlett 2017, 28, DOI: 10.1055/s-0036-1588840
Protein–protein interactions (PPIs) regulate a number of essential biochemical processes as well as cellular events. Modulation of PPIs is emerging as an attractive strategy
Protein synthesis and crystallization of Bowman–Birk protease inhibitorsvergrößern
Dr. Tornøe said: “In this paper, we use a divergent protein synthesis approach to modulate PPIs with disulfide-rich proteins, Bowman–Birk protease inhibitor